News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Annie Guérin

Articles by Annie Guérin

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC

Ivonescimab/Chemotherapy Maintains OS Benefit in EGFR-Mutant NSCLC

Sequencing CAR T-Cell Therapy With Bispecifics in Follicular Lymphoma

Considering CAR T vs Bispecific Antibodies in R/R Follicular Lymphoma

Optimal Sequencing of Bispecific Antibodies and CAR T Cells Remains Unclear